Up-regulation of type 1 plasminogen activator inhibitor messenger RNA with thrombotic changes in renal grafts

Transplantation

Volumn 61, Issue 5, 1996, Pages 684-689

  Wang, Yiming ^a,b   Pratt, Julian R ^a   Tam, Frederick W K ^c   Hartley, Barrie ^a   Wolff, Judith A ^a   Olavesen, Mark G ^a   Sacks, Steven H ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b GUY S HOSPITAL   (United Kingdom)

^c HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; PLASMINOGEN ACTIVATOR INHIBITOR 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL INJURY; GENE EXPRESSION; HISTOPATHOLOGY; IN SITU HYBRIDIZATION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; NONHUMAN; PATHOGENESIS; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROTEIN DETERMINATION; RNA ANALYSIS; THROMBOSIS;

ANIMALS; BASE SEQUENCE; BLOTTING, NORTHERN; GENE EXPRESSION REGULATION; GRAFT REJECTION; IN SITU HYBRIDIZATION; KIDNEY TRANSPLANTATION; MOLECULAR SEQUENCE DATA; PLASMINOGEN ACTIVATOR INHIBITOR 1; RATS; RATS, INBRED LEW; RNA, MESSENGER; THROMBOSIS; TRANSPLANTATION, HOMOLOGOUS; UP-REGULATION;

EID: 0029929452     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199603150-00002     Document Type: Article

References (37)

1. Bergstein JM. Glomerular fibrin deposition and removal. Pediatr Nephrol 1990; 4: 78.
2. Kruithof EKO. Plasminogen activator inhibitors - a review. Enzyme 1988; 40: 113.
3. Faulk WP, Gargiulo P, Mcintyre JA, Bang NU. Hemostasis and fibrinolysis in renal transplantation. Semin Thromb Hemost 1989; 15: 88.
4. Sraer JD, Kanfer A. Glomerular hemostasis in normal and pathological conditions. Adv Nephrol 1988; 17: 27.
5. Kruithof EKO, Tran-Thang C, Gudinchet A, et al. Fibrinolysis in pregnancy: a study of plasminogen activator inhibitors. Blood 1987; 69: 460.
6. Chapman HA Jr, Stone OL. Characterisation of a macrophage-derived plasminogen activator inhibitor. Biochem J 1985; 230: 109.
7. Sprengers ED, Kluft C. Plasminogen activator inhibitors. Blood 1987; 69: 381.
8. Wang Y, Thompson EM, Whawell SA, Fleming KA. Expression and localisation of plasminogen activator inhibitor 1 mRNA in transplant kidneys. J Pathol 1993; 169: 445.
9. Levi M, Wilmink J, Buller HR, Surachno J, ten Cate JW. Impaired fibrinolysis in cyclosporine-treated renal transplant patients: analysis of the defect and beneficial effect of fish-oil. Transplantation 1992; 54: 978.
10. Fabre J, Lim SH, Morris PJ. Renal transplantation in the rat: details of a technique. Aust N Z J Surg 1971; 41: 67.
11. McDonald RJ, Swift RJ, Przybyla AE, Chirgwin JH. Isolation of RNA using guanidinium salts. Methods Enzymol 1987; 152: 217.
12. Zeheb R, Gelehrter TD. Cloning and sequencing of cDNA for rat plasminogen activator inhibitor-1. Gene 1988; 73: 459.
13. Belin D, Wohlwend A, Schleuning W-D, Kruithof EKO, Vassalli JD. Facultative polypeptide translocation allows a single mRNA to encode the secreted and cytosolic forms of plasminogen activator inhibitor 2. EMBO J 1989; 8: 3287.
14. Tam FWK, Smith J, Cashman SJ, Wang Y, Thompson EM, Rees AJ. Glomerular expression of interleukine-1 receptor antagonist and interleukin-1 beta genes in antibody-mediated glomerulonephritis. Am J Pathol 1994; 145: 126.
15. de Bart ACW, Quax PHA, Schalken JH, Verheijen JH. u-PA production and u-PA mediated extracellular matrix degradation by rat prostate cancer lines in vitro correlates with metastatic behaviour in vivo. Fibrinolysis 1994; 8 (suppl 1): 57.
16. Vassalli J-D, Wohlwend A, Belin D. Urokinase-catalyzed plasminogen activation at the monocyte/macrophage cell surface: a localized and regulated proteolytic system. In: Russell FW, Gordon S, eds. Current topics in microbiology and immunology. Berlin: Springer-Verlag, 1992: 65.
17. An SF, Franklin D, Fleming KA. Generation of digoxigenin-labelled double-stranded and single-stranded probes using the polymerase chain reaction. Mol Cell Probes 1992; 6: 193.
18. Fleming KA, Evans M, Ryley KC, Franklin D, Lovell-Badge RH, Morey AL. Optimisation of non-isotopic in situ hybridisation on formalin-fixed paraffin-embedded material using digoxigenin labelled probes and transgenic tissues. J Pathol 1992; 167: 9.
19. Wang Y, Turner N, An SF, Fleming KA, Thompson EM. Gene expression of plasminogen activator inhibitor 1 in transplant kidneys complicated by renal vein thrombosis: a combined study by in situ hybridisation and immunohistochemistry. Nephrol Dial Transplant 1994; 9: 296.
20. Quax PHA, van den Hoogen M, Verheijen JH, et al. Endotoxin induction of plasminogen activator and plasminogen activator inhibitor type 1 mRNA in rat tissue in vivo. J Biol Chem 1990; 265: 15560.
21. Keeton M, Eguchi Y, Sawdey M, Ahn C, Loskutoff DJ. Cellular localization of type 1 plasminogen activator inhibitor messenger RNA and protein in murine renal tissue. Am J Pathol 1993; 142: 59.
22. Keeton M, Ahn C, Eguchi Y, Burlingame R, Loskutoff DJ. Expression of type 1 plasminogen activator inhibitor in renal tissue in murine lupus nephritis. Kidney Int 1995; 47: 148.
23. Peraldi MN, Rondeau E, Medcalf RL, et al. Cell-specific regulation of plasminogen activator inhibitor 1 and tissue type plasminogen activator release by human kidney mesangial cells. Biochim Biophys Acta 1992; 1134: 189.
24. Moll S, Schifferli JA, Huarte J, Lemoine R, Vassalli J-D, Sappino A-P. LPS induces major changes in the extracellular proteolytic balance in the murine kidney. Kidney Int 1994; 45: 500.
25. Thalacker FW, Nilsen-Hamilton M. Opposite and independent actions of cyclic AMP and transforming growth factor beta in the regulation of type 1 plasminogen activator inhibitor expression. Biochem J 1992; 287: 855.
26. Wojta J, Nakamura T, Fabry A, et al. Hepatocyte growth factor stimulates expression of plasminogen activator inhibitor type 1 and tissue factor in HepG2 cells. Blood 1994; 84: 151.
27. Campbell IK, Last K, Novak U, Lund LR, Hamilton JA. Recombinant human interleukin 1 inhibits plasminogen activator inhibitor 1 (PAI-1) production by human articular cartilage and chondrocytes. Biochem Biophys Res Commun 1991; 174: 251.
28. Campbell IK, Wojta J, Novak U, Hamilton JA. Cytokine modulation of plasminogen activator inhibitor 1 (PAI-1) production by human articular cartilage and chondrocytes. Down-regulation by tumor necrosis factor alpha and up- regulation by transforming growth factor beta, basic fibroblast growth factor. Biochim Biophys Acta 1994; 1226: 277.
29. Higgins PJ, Ryan MP, Providence KM. Induced expression of p52 (PAI-1) in normal rat kidney cells by the microfilament-disrupting agent cytochalasin D. J Cell Physiol 1994; 159: 187.
30. Sawdey MS, Loskutoff DJ. Regulation of murine type 1 plasminogen activator inhibitor gene expression in vivo. Tissue specificity and induction by lipopolysaccharide, tumor necrosis factor-alpha, and transforming growth factor-beta. J Clin Invest 1991; 88: 1346.
31. White JE, Ryan MP, Tsan MF, Higgins MP. Hyperoxic stress elevates p52 (PAI-1) mRNA abundance in cultured cells and adult rat pulmonary tissue. Am J Physiol 1993; 265: L121.
32. Tomosugi N, Wada T, Naito T, et al. Role of plasminogen activator inhibitor on nephrotoxic nephritis and its modulation by tumor necrosis factor. Nephron 1992; 62: 213.
33. Tilney NL, Whitley WD, Tullius SG, et al. Serial analysis of cytokines, adhesion molecule expression, and humoral responses during development of chronic kidney allograft rejection in a new rat model. Transplant Proc 1993; 25: 861.
34. Mannon RB, Sundar SK, Sanfilippo FP, Coffman TM. Alterations in renal interleukin-1 production during kidney transplant rejection in the rat. The effects of high-dose methylprednisolone. Transplantation 1993; 56: 1157.
35. Juhan-Vaigue I, Aillaud MF, de Cock F, et al. The fast-acting inhibitor of tissue plasrainogen activator is an acute phase reactant protein. In: Davidson JF, Donati MB, Coccheri S, eds. Progress in fibrinolysis. Edinburgh: Churchill Livingstone, 1985: 146.
36. Kushner I. The acute phase response: an overview. Methods Enzymol 1988; 163: 373.
37. Podor TJ, Hirsh J, Gelehrter TD, et al. Type 1 plasminogen activator inhibitor is not an acute phase reactant in rats. J Immunol 1993; 150: 225.